| Primary |
| Influenza |
25.3% |
| H1n1 Influenza |
17.3% |
| Avian Influenza |
9.3% |
| Antiviral Prophylaxis |
8.0% |
| Sedation |
8.0% |
| Anti-infective Therapy |
4.0% |
| Immunosuppression |
4.0% |
| Pneumonitis |
4.0% |
| Pain |
2.7% |
| Pneumonia |
2.7% |
| Prophylaxis |
2.7% |
| Drug Therapy |
1.3% |
| Hypotension |
1.3% |
| Hypothyroidism |
1.3% |
| Influenza A Virus Infection |
1.3% |
| Influenza Like Illness |
1.3% |
| Influenza Virus Test Positive |
1.3% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.3% |
| Renal Failure |
1.3% |
| Sedative Therapy |
1.3% |
|
| Pregnancy |
24.5% |
| Drug Exposure During Pregnancy |
16.0% |
| No Adverse Event |
11.7% |
| Normal Newborn |
10.6% |
| Death |
6.4% |
| Abortion Spontaneous |
3.2% |
| Premature Labour |
3.2% |
| Pulmonary Embolism |
3.2% |
| Small For Dates Baby |
3.2% |
| Convulsion |
2.1% |
| Cytolytic Hepatitis |
2.1% |
| Pneumonia |
2.1% |
| Premature Baby |
2.1% |
| Respiratory Failure |
2.1% |
| Thrombocytopenia |
2.1% |
| Aggression |
1.1% |
| Drug Exposure Before Pregnancy |
1.1% |
| Foetal Disorder |
1.1% |
| Foetal Heart Rate Disorder |
1.1% |
| Hypoxia |
1.1% |
|
| Secondary |
| Product Used For Unknown Indication |
21.8% |
| Drug Use For Unknown Indication |
19.8% |
| Hypertension |
11.2% |
| H1n1 Influenza |
8.6% |
| Influenza |
4.1% |
| Pharyngeal Erythema |
4.1% |
| Pyrexia |
4.1% |
| Muscle Spasms |
3.0% |
| Otitis Media |
3.0% |
| Pneumonia |
3.0% |
| Antibiotic Prophylaxis |
2.0% |
| Immunosuppression |
2.0% |
| Large Intestine Carcinoma |
2.0% |
| Mycobacterium Fortuitum Infection |
2.0% |
| Prophylaxis |
2.0% |
| Viral Infection |
2.0% |
| Aspergillosis |
1.5% |
| Thalassaemia Beta |
1.5% |
| Abdominal Discomfort |
1.0% |
| Chronic Myeloid Leukaemia |
1.0% |
|
| Erythema Multiforme |
13.8% |
| Septic Shock |
10.3% |
| H1n1 Influenza |
6.9% |
| Pneumonia |
6.9% |
| Rash |
6.9% |
| Renal Failure |
6.9% |
| Abortion Induced |
3.4% |
| Abortion Spontaneous |
3.4% |
| Altered State Of Consciousness |
3.4% |
| Atrial Fibrillation |
3.4% |
| Diarrhoea |
3.4% |
| Haemolytic Anaemia |
3.4% |
| Hypoxia |
3.4% |
| Infection In An Immunocompromised Host |
3.4% |
| Interstitial Lung Disease |
3.4% |
| Laboratory Test Abnormal |
3.4% |
| Maternal Drugs Affecting Foetus |
3.4% |
| Maternal Exposure During Pregnancy |
3.4% |
| Neurotoxicity |
3.4% |
| Oedema |
3.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
25.5% |
| Prophylaxis |
8.9% |
| Drug Use For Unknown Indication |
8.4% |
| Hiv Infection |
6.6% |
| Aplastic Anaemia |
5.6% |
| Infection Prophylaxis |
4.8% |
| Bronchitis |
4.6% |
| Bone Marrow Conditioning Regimen |
3.8% |
| Gastrointestinal Disorder |
3.8% |
| Glycogen Storage Disease Type Ii |
3.3% |
| Influenza |
3.3% |
| Antifungal Prophylaxis |
2.8% |
| Prophylaxis Against Graft Versus Host Disease |
2.8% |
| Insomnia |
2.6% |
| Rhinitis Allergic |
2.6% |
| Gastritis Prophylaxis |
2.3% |
| Pain |
2.3% |
| Iron Overload |
2.0% |
| Rheumatoid Arthritis |
2.0% |
| H1n1 Influenza |
1.8% |
|
| White Blood Cell Count Decreased |
12.8% |
| Pneumonia |
10.3% |
| Pyrexia |
10.3% |
| Vomiting |
10.3% |
| Bradycardia |
5.1% |
| Drug Exposure During Pregnancy |
5.1% |
| Liver Disorder |
5.1% |
| Rhinitis Allergic |
5.1% |
| Sick Sinus Syndrome |
5.1% |
| Tendon Rupture |
5.1% |
| Anaemia |
2.6% |
| Blood Alkaline Phosphatase Increased |
2.6% |
| Blood Lactate Dehydrogenase Increased |
2.6% |
| Bronchopulmonary Aspergillosis |
2.6% |
| Encephalopathy |
2.6% |
| Febrile Neutropenia |
2.6% |
| Hepatic Enzyme Abnormal |
2.6% |
| Hypertension |
2.6% |
| Lower Respiratory Tract Infection |
2.6% |
| Myocardial Infarction |
2.6% |
|
